Aileron Therapeutics Appoints Evan Lippman As Chief Financial And Business Officer

Aileron Therapeutics, Inc., a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug platform, today announced that it has expanded its senior management team with the appointment of industry veteran Evan Lippman as the Company’s first Chief Financial and Business Officer.

Help employers find you! Check out all the jobs and post your resume.

Back to news